EGF-induced apoptosis in A431 cells is dependent on STAT1, but not on STAT3

European Journal of Cell Biology

Volumn 86, Issue 10, 2007, Pages 591-603

  Grudinkin, Pavel S ^a   Zenin, Valery V ^a   Kropotov, Andrey V ^a   Dorosh, Viktoria N ^a   Nikolsky, Nikolay N ^a  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

Author keywords

A431 cells; Apoptosis; Epidermal growth factor; shRNA; STAT1; STAT3

Indexed keywords

EPIDERMAL GROWTH FACTOR; MUTANT PROTEIN; PROTEIN TYROSINE KINASE; SHORT HAIRPIN RNA; STAT1 PROTEIN; STAT3 PROTEIN;

APOPTOSIS; ARTICLE; CELL CLONING; CELL CYCLE PHASE; CELL GROWTH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 34548628970     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcb.2007.05.009     Document Type: Article

References (43)

1. Anto R.J., Venkatraman M., and Karunagaran D. Inhibition of NF-κB sensitizes A431 cells to epidermal growth factor-induced apoptosis, whereas its activation by ectopic expression of RelA confers resistance. J. Biol. Chem. 278 (2003) 25490-25498
2. Battle T.E., and Frank D.A. The role of STATs in apoptosis. Curr. Mol. Med. 2 (2002) 381-392
3. Beguinot L., Lyall R.M., Willingham M.C., and Pastan I. Down-regulation of the epidermal growth factor receptor in KB cells is due to receptor internalization and subsequent degradation in lysosomes. Proc. Natl. Acad. Sci. USA 81 (1984) 2384-2388
4. Behzadian M.A., and Shimizu N. Variant of A431 cells isolated by ricin A-conjugated monoclonal antibody directed to EGF receptor: phosphorylation of EGF receptor and phosphatidylinositol. Somat. Cell Mol. Genet. 11 (1985) 579-591
5. Bromberg J.F. Activation of STAT proteins and growth control. BioEssays 23 (2001) 161-169
6. Bromberg J.F., Fan Z., Brown C., Mendelsohn J., and Darnell Jr. J.E. Epidermal growth factor-induced growth inhibition requires Stat1 activation. Cell Growth Differ. 9 (1998) 505-512
7. Buss J.E., Kudlow J.E., Lazar C.S., and Gill G.N. Altered epidermal growth factor (EGF)-stimulated protein kinase activity in variant A431 cells with altered growth responses to EGF. Proc. Natl. Acad. Sci. USA 79 (1982) 2574-2578
8. Busse D., Doughty R.S., Ramsey T.T., Russell W.E., Price J.O., Flanagan W.M., Shawver L.K., and Arteaga C.L. Reversible G1 arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27KIP1 independent of MAPK activity. J. Biol. Chem. 275 (2000) 6987-6995
9. Chin Y.E., Kitagawa M., Su W.-C.S., You Z.-H., Iwamoto Y., and Fu X.-Y. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21WAF1/CIP1 mediated by STAT. Science 272 (1996) 719-722
10. Chin Y.E., Kitagawa M., Kuida K., Flavell R.A., and Fu X.-Y. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell. Biol. 17 (1997) 5328-5337
11. Darnell Jr. J.E. STATs and gene regulation. Science 277 (1997) 1630-1635
12. Fan Z., Lu Y., Wu X., DeBlasio A., Koff A., and Mendelsohn J. Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition. J. Cell Biol. 131 (1995) 235-242
13. Garcia R., Bowman T.L., Niu G., Yu H., Minton S., Muro-Cacho C.A., Cox C.E., Falcone R., Fairclough R., Parsons S., Laudano A., Gazit A., Levitzki A., Kraker A., and Jove R. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20 (2001) 2499-2513
14. Gill G.N., and Lazar C.S. Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells. Nature 293 (1981) 305-307
15. Grudinkin P.S., Bagaeva V.V., and Nikol'skii N.N. EGF-induced signal transduction in clonal cells of epidermoid carcinoma A431. Tsitologiia 45 (2003) 158-165
16. Gudkova D.A., and Sorokin A.B. Cell strains of A431 epidermoid carcinoma with altered epidermal growth factor reception. Tsitologiia 31 (1989) 319-323
17. Gulli L.F., Palmer K.C., Chen Y.Q., and Reddy K.B. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity. Cell Growth Differ. 7 (1996) 173-178
18. Gullick W.J. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br. Med. Bull. 47 (1991) 87-98
19. Jakus J., and Yeudall W.A. Growth inhibitory concentrations of EGF induce p21WAF1/Cip1 and alter cell cycle control in squamous carcinoma cells. Oncogene 12 (1996) 2369-2376
20. Jorissen R.N., Walker F., Pouliot N., Garrett T.P.J., Ward C.W., and Burgess A.W. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp. Cell Res. 284 (2003) 31-53
21. Karni R., Jove R., and Levitzki A. Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors. Oncogene 18 (1999) 4654-4662
22. Kisseleva T., Bhattacharya S., Braunstein J., and Schindler C.W. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285 (2002) 1-24
23. Kumar A., Commane M., Flickinger T.W., Horvath C.M., and Stark G.R. Defective TNF-α-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 278 (1997) 1630-1632
24. MacLeod C.L., Luk A., Castagnola J., Cronin M., and Mendelsohn J. EGF induces cell cycle arrest of A431 human epidermoid carcinoma cells. J. Cell. Physiol. 127 (1986) 175-182
25. Masui H., Kawamoto T., Sato J.D., Wolf B., Sato G., and Mendelsohn J. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res. 44 (1984) 1002-1007
26. Missbach M., Jeschke M., Feyen J., Muller K., Glatt M., Green J., and Susa M. A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo. Bone 24 (1999) 437-449
27. Morazzani M., de Carvalho D.D., Kovacic H., Smida-Rezgui S., Briand C., and Penel C. Monolayer versus aggregate balance in survival process for EGF-induced apoptosis in A431 carcinoma cells: implication of ROS-p38 MAPK-integrin α2β1 pathway. Int. J. Cancer 110 (2004) 788-799
28. Nesterov A., Reshetnikova G., Vinogradova N., and Nikolsky N. Functional state of the epidermal growth factor-receptor complexes during their internalization in A-431 cells. Mol. Cell. Biol. 10 (1990) 5011-5014
29. Ohtsubo M., Gamou S., and Shimizu N. Antisense oligonucleotide of WAF1 gene prevents EGF-induced cell-cycle arrest in A431 cells. Oncogene 16 (1998) 797-802
30. Ohtsubo M., Takanagi A., Gamou S., and Shimizu N. Interruption of NFκB-STAT1 signaling mediates EGF-induced cell-cycle arrest. J. Cell. Physiol. 184 (2000) 131-137
31. Olayioye M.A., Beuvink I., Horsch K., Daly J.M., and Hynes N.E. ErbB receptor-induced activation of STAT transcription factors is mediated by Src tyrosine kinases. J. Biol. Chem. 274 (1999) 17209-17218
32. Rubin Grandis J., Drenning S.D., Chakraborty A., Zhou M.Y., Zeng Q., Pitt A.S., and Tweardy D.J. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J. Clin. Invest. 102 (1998) 1385-1392
33. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 103 (2000) 211-225
34. Smida Rezgui S., Honore S., Rognoni J.B., Martin P.M., and Penel C. Up-regulation of α2β1 integrin cell-surface expression protects A431 cells from epidermal growth factor-induced apoptosis. Int. J. Cancer 87 (2000) 360-367
35. Sorkin A., Kornilova E., Teslenko L., Sorokin A., and Nikolsky N. Recycling of epidermal growth factor-receptor complexes in A431 cells. Biochim. Biophys. Acta 1011 (1989) 88-96
36. Stephanou A., and Latchman D.S. Opposing actions of STAT-1 and STAT-3. Growth Factors 23 (2005) 177-182
37. Townsend P.A., Scarabelli T.M., Davidson S.M., Knight R.A., Latchman D.S., and Stephanou A. STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis. J. Biol. Chem. 279 (2004) 5811-5820
38. Toyoda M., Gotoh N., Handa H., and Shibuya M. Involvement of MAP kinase-independent protein kinase C signaling pathway in the EGF-induced p21WAF1/Cip1 expression and growth inhibition of A431 cells. Biochem. Biophys. Res. Commun. 250 (1998) 430-435
39. Van de Vijver M.J., Kumar R., and Mendelsohn J. Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly. J. Biol. Chem. 266 (1991) 7503-7508
40. Watanabe G., Kaganoi J., Imamura M., Shimada Y., Itami A., Uchida S., Sato F., and Kitagawa M. Progression of esophageal carcinoma by loss of EGF-STAT1 pathway. Cancer J. 7 (2001) 132-139
41. Xie W., Su K., Wang D., Paterson A.J., and Kudlow J.E. MDA468 growth inhibition by EGF is associated with the induction of the cyclin-dependent kinase inhibitor p21WAF1. Anticancer Res. 17 (1997) 2627-2633
42. Xu X., Fu X.-Y., Plate J., and Chong A.S. IFN-γ induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for upregulation of Fas and Fas-L expression. Cancer Res. 58 (1998) 2832-2837
43. Yu J.-Y., DeRuiter S.L., and Turner D.L. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA 99 (2002) 6047-6052